Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ford Motor Company (F), General Motors Company (GM): What’s Holding These Automakers’ Stock Prices Down?

Page 1 of 2

Ford Motor Company (NYSE:F)January and February were two great months for vehicle sales in the U.S. market, delivering great sales figures, profits, and renewed optimism at Detroit automakers Ford Motor Company (NYSE:F) and General Motors Company (NYSE:GM). In those same two months, however, the stock prices of Ford and GM haven’t responded – both companies lag the broader market. With a rebounding U.S. market, and gaining share in China, it’s clear Europe is the biggest cause of pressure on domestic auto stocks. I bet you’re shocked, huh? There’s no need to panic or avoid these stocks, for the European market will bottom out and rebound eventually. What’s important is understanding if the rebound will resemble the U.S. market or the Japanese market. If you don’t know the difference, then read on; it will make a huge difference in the stock prices through 2020.

Japan or U.S.
Ford Motor Company (NYSE:F) expects to lose more money in Europe in 2013 than it did in 2012. Not good news from a company that lost $1.8 billion there last year. Analysts expect sales to start recovering in 2014, but they see a slow and gradual rebound. Vehicle sales aren’t expected to reach pre-crisis levels until the end of the decade, at least. That’s terrible news considering that the European auto market once was the largest in the world.

Some analysts now believe Europe could resemble Japan’s auto recovery rather than that of the United States. “Auto sales in the U.S. recovered to 14.4 million in 2012, up 13.4 percent from 2011 and 39 percent from 2009. This was in contrast to previous market assumptions and forecasts pointing to long-lasting depressed conditions,” Emmanuel Bulle, Paris-based autos analyst with Fitch Ratings said.

He goes on to mention that Japan’s vehicle sales have fluctuated between 25% and 45% below its 1990 peak, never fully recovering. If that’s the case, and the European consumer doesn’t fully return, it makes maintaining market share in the U.S. and growth in China the most important factors going forward. There is hope though; let’s look at a few factors that will help Ford and General Motors Company (NYSE:GM) get out of this rut.

Been there, done that
Obviously, industry sales are expected to decline again this year, but consider some other factors. There are advertisements that are offering discounts equivalent to over $9,000 per vehicle. Some nations are also considering scrap programs, similar to our cash-for-clunkers program, which would make it even more difficult for automakers to estimate needed inventories. Any of that sound familiar? It’s 2008 all over again, with a European twist.

Alan Mulally, Ford Motor Company (NYSE:F)’s CEO, still expects to lose $3 billion over the next two years in Europe. That said, the company has seen much worse and come out better than ever. Consider that between 2006 and 2008 Ford lost $30 billion due to the U.S. recession — or 10 times more than it expects to lose in Europe over the next two years. Ford plans to use the same cost-cutting tactics that helped return Ford to profitability in 2009. This time it will use the tactics in Europe. The plan is to cut costs by $500 million a year and reduce in-stock vehicle inventory by 20%. It will also be cutting factory capacity, which has been difficult due to political pressure. This adversity isn’t anything new, and much easier to handle than the 2008 U.S. crisis. Mulally and Ford have been there, done that, and I expect them to get the job done again.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!